News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Angelo Dipasquale: Prognostic signature of patients with astrocytoma IDHm G4
Photo from Angelo Dipasquale/LinkedIn
Jun 6, 2024, 11:44

Angelo Dipasquale: Prognostic signature of patients with astrocytoma IDHm G4

“Just out our large experience exploring prognostic signature of patients with astrocytoma IDHm G4.

Shedding some light on this ‘grey-zone’ entity between IDHm and IDHwt gliomas!”

Angelo Dipasquale: Prognostic signature of patients with astrocytoma IDHm G4

Visit the article website.
Source:

 

AIOM Angelo Dipasquale Associazione Italiana di Oncologia Medica astrocytoma astrocytoma IDHm G4 cancer EANO European Association of Neuro-oncology Federico Pessina gliomas Humanitas Research Hospital Humanitas University IDHm IDHwt OncoDaily Oncology Research
Special Coverage
Blog
Feb 11, 2025, 03:46
Historical Perspective of Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Blog
Feb 10, 2025, 18:28
Narjust Florez: Thank you ASCO - never imagined this to happen when still in my 30s
Blog
Feb 10, 2025, 18:24
Stephanie Graff: Thank you, ASCO, for the beautiful award
Science
Feb 10, 2025, 18:20
Leela Morená: Xenotransplantation of a porcine kidney for end-stage kidney disease
Blog
Feb 10, 2025, 18:17
New 2025-2027 committee nominations are now open - IASLC
Blog
Feb 10, 2025, 18:10
Rasu Shrestha: Proud of what we, as a team across Advocate Health, have already accomplished
Blog
Feb 10, 2025, 17:17
Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Blog
Feb 10, 2025, 16:55
Did you know that some cancer treatments cause cardiotoxicity? - Oncogene Cancer Research
Blog
Feb 10, 2025, 16:49
AAMC Statement on Drastic Cuts to NIH-Funded Research
Science
Feb 10, 2025, 16:45
Patrick Hwu: The potential of personalized cancer vaccines as an effective adjuvant therapy in RCC
Insight
Feb 10, 2025, 16:08
Drew Moghanaki: A common-sense interpretation of clinical trial data
Blog
Feb 10, 2025, 15:56
Herbert Loong: Join us for the inaugural ESMO TAT Asia 2025 meeting